The present invention is directed to an amide derivative having excellent BCR-ABL tyrosine kinase inhibitory activity, or a salt thereof. The present invention provides an amide derivative represented by the following general formula [1]: (wherein R 1 represents -CH 2 -R 11 , etc. R 2 represents alkyl, halogen, haloalkyl, etc. R 3 represents hydrogen, etc. Het1 represents a group of the formula [6] as above, etc. and Het2 represents pyrimidinyl, etc.), or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same as an active ingredient. The compound of the present invention is useful as a BCR-ABL tyrosine kinase inhibitor.
